<ѻýҕl>Adding Tirzepatide to Basal Insulin Cuts HbA1c in Poorly Controlled T2Dѻýҕl> Results with the GIP/GLP-1 receptor agonist were statistically superior to added insulin lispro Oct 03, 2023
<ѻýҕl>Pharmacists Improve Diabetes Control for Hispanic Patientsѻýҕl> Medication-adjustment recommendations were linked to some improvements in type 2 diabetes Oct 02, 2023
<ѻýҕl>FDA Adds Intestinal Blockage Reports to Ozempic Labelingѻýҕl> Joins other approved GLP-1 receptor agonists in noting the potential adverse reaction Sep 28, 2023
<ѻýҕl>Postmenopausal Fracture Risk for SGLT2 Inhibitors Similar to Other Diabetes Drugsѻýҕl> Lower risk compared with DPP-4 inhibitors, and similar risk versus GLP-1 receptor agonists Sep 26, 2023
<ѻýҕl>FDA Panel: All Thumbs Down for GLP-1 Agonist Implant for Diabetesѻýҕl> We haven't seen "the best version of this device," said panel member Sep 22, 2023
<ѻýҕl>Third Time's a Charm for GLP-1 Diabetes Device? FDA Staff Suggest Otherwise.ѻýҕl> Advisory committee to weigh in on safety concerns with GLP-1 receptor agonist implant Sep 20, 2023
<ѻýҕl>Direct-to-Consumer Lab Tests Raise Ethical Questions, Researchers Sayѻýҕl> Privacy policies, terms of sale often are unclear Sep 18, 2023
<ѻýҕl>Keto for Kids With Diabetes Carries Risk, AAP Warnsѻýҕl> American Academy of Pediatrics outlines policy for low-, very low-carbohydrate diets Sep 18, 2023
<ѻýҕl>Is Being a Night Owl Unhealthy? CRC Screening Not Recommended Enoughѻýҕl> Also in TTHealthWatch: CVD death and obesity Sep 16, 2023 podcast
<ѻýҕl>Mask Attack Leaves Actor Blind; Diabetes Risk in Night Owls; U.S. Blood Shortageѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Sep 12, 2023
<ѻýҕl>When Temps Rise, So Do Medical Risks. Should Docs and Nurses Talk More About Heat?ѻýҕl> "This is not your grandmother's heat," says policy expert Sep 10, 2023
<ѻýҕl>Low-Dose Semaglutide Can Ease Insulin Need in Early T1D, Small Series Showsѻýҕl> All 10 patients were able to eliminate prandial insulin use within 3 months Sep 06, 2023
<ѻýҕl>Case Grows for SGLT2 Inhibitors as Gout Treatmentѻýҕl> Large cohort study shows expansive benefits Aug 28, 2023
<ѻýҕl>SGLT2 Inhibitors, Rapid Titration, IV Iron Get a Boost in New European HF Guidelineѻýҕl> Other recommendations also released for endocarditis, cardiomyopathies, ACS, and more Aug 25, 2023
<ѻýҕl>Should People Without Diabetes Use Glucose Monitors?ѻýҕl> Trend boosted by health buffs on social media, but benefit for healthy adults is unclear Aug 01, 2023
<ѻýҕl>Kombucha Shows Potential Diabetes Benefit in Small Trialѻýҕl> Diabetes patients saw glucose levels drop after drinking fermented tea Aug 01, 2023
<ѻýҕl>Albuminuria Testing Falling Short in Patients at Risk for CKDѻýҕl> If testing rates followed recommendations, some could start necessary meds sooner Jul 27, 2023
<ѻýҕl>Aspartame Is a 'Possible' Carcinogen, WHO Declaresѻýҕl> But the organization's recommended limits on aspartame consumption remain unchanged Jul 13, 2023
<ѻýҕl>Diabetes Projected to Affect 1.3 Billion People by 2050ѻýҕl> Advance of disease driven by high BMI, with social determinants of health playing a role Jun 28, 2023
<ѻýҕl>Protocol Optimizing Meds for T2D and CVD Pushed Beyond Cardiology Aloneѻýҕl> Endocrinologists urged to pay attention to COORDINATE trial Jun 27, 2023
<ѻýҕl>Semaglutide Plus Cagrilintide Reduced Blood Sugar, Weight in T2Dѻýҕl> Once-weekly CagriSema reduced body weight more than either agent alone Jun 27, 2023
<ѻýҕl>High-Dose Semaglutide Pill Just as Effective as Wegovy for Weight Lossѻýҕl> Another study showed two high doses were better at reducing HbA1c vs a 14-mg dose Jun 27, 2023
<ѻýҕl>Novel Triple Agonist Nabs Biggest Weight Loss Yet in Obesity Trialѻýҕl> Plus, two other studies on retatrutide show benefit in type 2 diabetes, fatty liver disease Jun 26, 2023
<ѻýҕl>Bempedoic Acid Gets 'Huge' Win for Primary Prevention in the Statin-Intolerantѻýҕl> More positive results in CLEAR Outcomes sub-analysis Jun 26, 2023
<ѻýҕl>Once-Weekly Insulin Icodec Bests Daily Insulin Options for Type 2 Diabetesѻýҕl> Superior to once-a-day insulin glargine U100 and degludec Jun 25, 2023
<ѻýҕl>Near 15% Weight Loss With Novel Oral GLP-1 RA in Phase II Obesity Trialѻýҕl> Daily orforglipron also lowered HbA1c in type 2 diabetes Jun 24, 2023
<ѻýҕl>Novel Agent Leads to Fibrosis Improvement in NASHѻýҕl> Phase IIb ENLIVEN trial saw success with various doses of pegozafermin Jun 24, 2023
<ѻýҕl>First SGLT2 Inhibitor Approved for Kids With Type 2 Diabetesѻýҕl> Now another oral option other than metformin Jun 21, 2023
<ѻýҕl>Wide Variation in CGM Settings for Kids With Diabetes Signals Education Gapsѻýҕl> Researcher warns of "alarm fatigue" if thresholds aren't optimized to patient Jun 20, 2023
<ѻýҕl>Early Time-Restricted Eating Cut Blood Sugar Fluctuations in Prediabetesѻýҕl> Effects in small study seen independent of weight loss Jun 18, 2023
<ѻýҕl>Anti-VEGF Injections for Diabetic Retinopathy Linked to Systemic Adverse Eventsѻýҕl> But question of associated adverse effects is still far from settled, editorialist says Jun 02, 2023
<ѻýҕl>FDA Warns on Certain Forms of Compounded Semaglutideѻýҕl> Some products may not contain the same active ingredient as the approved drugs Jun 01, 2023
<ѻýҕl>Sotagliflozin Gets FDA's Blessing for Heart Failureѻýҕl> SGLT1/SGLT2 inhibitor approved on the basis of SOLOIST-WHF, SCORED trials May 27, 2023
<ѻýҕl>Farxiga's Decongestion Flop; Benefit of Strong Legs; 2,500-Mile Heart Transportѻýҕl> Recent developments of interest in cardiovascular medicine May 23, 2023
<ѻýҕl>Topical Esmolol Gel Helped Heal Diabetic Foot Ulcersѻýҕl> Significantly better than standard of care at 12 and 24 weeks May 15, 2023
<ѻýҕl>Senators Call Out PBMs, Drugmakers for High Prescription Drug Costsѻýҕl> This "is a moral issue," Sen. Bernie Sanders said during the hearing May 11, 2023
<ѻýҕl>Adding This New Criteria Drastically Cut 72-Hour Insulinoma Fast Timeѻýҕl> Beta-hydroxybutyrate-based stopping point reduced burden on patients May 08, 2023
<ѻýҕl>GLP-1 Agonists Come Out on Top in Cardiovascular Comparison of Newer Diabetes Medsѻýҕl> Serious limitations noted of attempt to compare GLP-1 agonists, SGLT-2 inhibitors, however May 08, 2023
<ѻýҕl>GLP-1 RAs Safe Months After Kidney Transplantѻýҕl> Helped diabetics cut down on daily insulin dose, body weight May 08, 2023
<ѻýҕl>Vascular Complications Big Contributor to Diabetes Deathsѻýҕl> Diabetic nephropathy was most common of the fatal complications, study showed May 05, 2023